Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

To assess the beneficial and harmful effects of drugs improving insulin resistance for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

This is a protocol.